Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2018-316-320
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Correction: Discontinuation of Adalimumab After Achieving Remission in Patients With Established Rheumatoid Arthritis: 1-Year Outcome of the HONOR Study: Table 3

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2016English

Discontinuation of Adalimumab After Attaining Disease Activity Score 28-Erythrocyte Sedimentation Rate Remission in Patients With Rheumatoid Arthritis (HONOR Study): An Observational Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Patient’s Perspective of Sustained Remission in Rheumatoid Arthritis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

SAT0061 Haq Score Is an Independent Predictor of Sustained Remission in Patients With Rheumatoid Arthritis

2017English

Comment on ‘Sustained Discontinuation of Infliximab With a Raising-Dose Strategy After Obtaining Remission in Patients With Rheumatoid Arthritis: The RRRR Study, a Randomised Controlled Trial’ by Tanaka Et Al

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open
RheumatologyAllergyImmunology
2017English

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy

PLoS ONE
Multidisciplinary
2014English

Rheumatoid Arthritis-Associated Uveitis Treated With Adalimumab

Klinika Oczna
MedicineOphthalmology
2019English

Spontaneous Remission of Marginal Zone B Cell Lymphoma in a Patient With Seropositive Rheumatoid Arthritis After Discontinuation of Infliximab-Methotrexate Treatment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy